Back

Metformin will remain the first option in oral treatment of diabetes

28 August 2016 (08:52 - 09:15)
Organised by:
Congress Presentation Part of: Cardio-diabetology alliance - The myth busters Diabetes, dysglycaemia and metabolic syndrome ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Naveed Sattar

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Metabolically healthy obese people will populate the earth
Professor D. Gaita (Timisoara, RO)
Slides Video
Presentation thumbnail
Beta-blockers and diuretics are not neutral for metabolism
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Cardiovascular mortality cannot be decreased by antidiabetic drugs
Professor E. Standl (Munich, DE)
Slides Video

Access the full session

Session thumbnail
Cardio-diabetology alliance - The myth busters

The Event

Event poster

ESC Congress 2016

28 August 2016 08:52 CET
You may be interested in
thumbnail
Congress Presentation
All diabetic patients should be treated with metformin.
29 August 2022
thumbnail
Congress Presentation
Metformin reduces the risk of hospitalization for heart failure in type 2 diabetes patients: a retrospective cohort analysis
3 September 2019
thumbnail
Congress Presentation
Diabetes and contemporary treatment of chronic heart failure in a large real-world heart failure population
29 June 2021
thumbnail
Congress Presentation
GLP1-RA versus metformin as first-line therapy for achieving glycemic control and risk-factor management - a one-year nationwide cohort study
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources